Skip to contentE
Envoy Medical, Inc.
E
COCHEnvoy Medical, Inc. Q2 2026 · 10-Q
Revenue$51.00K$51.00K−34.6% vs Q2 2025 Net Income-$5.98M-$5.98MN/M vs Q2 2025 EPS Diluted-$0.07-$0.07N/M vs Q2 2025 Operating Income-$5,569,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Envoy Medical, Inc. · CIK 1840877 · Engraved from SEC EDGAR
derived
Margins · derivedOperating margin-10919.6%−4419.6 pt vs Q2 2025
Net margin-11729.4%−4434.5 pt vs Q2 2025
ended Jun 30, 2026 · filed Aug 10, 2026 · 41 d after period end